Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ADA Standards of Medical Care in Diabetes: implications for Older Adults.

The Senior care pharmacist·2020
Same author

Understanding Clinical Laboratory Interference.

The Senior care pharmacist·2019
Same author

The Other Side of the Opioid Debate: Treating Older Adults With Chronic Pain.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same author

Getting Paid for Clinical Services.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same author

Controlling Diabetes: Continuous Glucose Monitoring for the Older Adult.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same author

Demystifying Probiotics: Use in the Elderly.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2017

Related Experiment Video

Updated: May 28, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

MDS: valuable clinical data that can help improve medication therapy.

Caren McHenry Martin1

  • 1consultant pharmacist in Greensboro, North Carolina.

The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|October 19, 2011
PubMed
Summary

The Minimum Data Set (MDS) is a mandated nursing facility assessment tool. It provides valuable resident data to help consultant pharmacists improve medication reviews.

Area of Science:

  • Gerontology
  • Health Services Research
  • Clinical Pharmacy

Background:

  • The Minimum Data Set (MDS) is a standardized assessment tool used in nursing facilities.
  • Its use is mandated by the Centers for Medicare & Medicaid Services (CMS).
  • The MDS collects comprehensive clinical information on nursing facility residents.

Purpose of the Study:

  • To highlight the utility of the Minimum Data Set (MDS) in clinical pharmacy practice.
  • To demonstrate how MDS data can enhance medication regimen reviews for nursing facility residents.

Main Methods:

  • Review of the Minimum Data Set (MDS) assessment tool and its data components.
  • Analysis of how MDS-collected clinical information can be applied to medication management.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Experiment Videos

Last Updated: May 28, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Main Results:

  • MDS data offers detailed insights into resident health status, diagnoses, and functional abilities.
  • This clinical information is crucial for identifying potential drug-related problems and optimizing pharmacotherapy.

Conclusions:

  • The Minimum Data Set (MDS) is an indispensable tool for consultant pharmacists.
  • Leveraging MDS data facilitates more effective and efficient medication regimen reviews, ultimately improving resident care in nursing facilities.